Dudediligence.

Rapport Therapeutics, Inc

RAPPNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$46.1M

24 notices · 1,171,986 sh

Oct 2025 to Oct 2026

Reported ·

$39.6M

48 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

45 of 48 reported sales carry the 10b5-1 box. Together they are 2.14% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-30: CHERYL GAULT, Form 1442026-08-25: KRISHNASWAMY YELESWARAM, Form 1442026-08-24: KRISHNASWAMY YELESWARAM, Form 1442026-08-19: KRISHNASWAMY YELESWARAM, Form 1442026-06-30: CHERYL GAULT, Form 1442026-06-29: Abraham N. Ceesay, Form 1442026-05-26: Third Rock Ventures V, L.P., Form 1442026-05-11: Third Rock Ventures V, L.P., Form 1442026-05-08: Third Rock Ventures V, L.P., Form 1442026-05-07: Third Rock Ventures V, L.P., Form 1442026-04-17: Third Rock Ventures V, L.P., Form 1442026-04-17: KRISHNASWAMY YELESWARAM, Form 1442026-04-13: KRISHNASWAMY YELESWARAM, Form 1442026-04-10: KRISHNASWAMY YELESWARAM, Form 1442026-04-08: KRISHNASWAMY YELESWARAM, Form 1442026-03-30: CHERYL GAULT, Form 1442026-03-25: KRISHNASWAMY YELESWARAM, Form 1442026-03-05: Gault Cheryl, Form 1442026-01-15: DAVID BREDT, Form 1442026-01-02: DAVID BREDT, Form 1442026-01-02: Krishnaswamy Yeleswaram, Form 1442025-12-17: THE DOROTHY CEESAY IRREVOCABLE TRUST, Form 1442025-12-17: ABRAHAM CEESAY, Form 1442025-10-15: DAVID BREDT, Form 1442025-10-15: Ceesay Abraham, sold2025-10-15: Bredt David, sold2025-11-17: Bredt David, sold2025-11-17: Ceesay Abraham, sold2025-11-26: Gault Cheryl, sold2025-12-15: Bredt David, sold2025-12-17: Ceesay Abraham, sold2025-12-31: Yeleswaram Krishnaswamy, sold2025-12-31: Bredt David, sold2026-01-15: Bredt David, sold2026-01-20: Ceesay Abraham, sold2026-02-17: Bredt David, sold2026-02-18: Ceesay Abraham, sold2026-03-05: Gault Cheryl, sold2026-03-25: Yeleswaram Krishnaswamy, sold2026-03-30: Gault Cheryl, sold2026-04-08: Yeleswaram Krishnaswamy, sold2026-04-10: Yeleswaram Krishnaswamy, sold2026-04-17: Yeleswaram Krishnaswamy, sold2026-04-17: Third Rock Ventures V, L.P., sold2026-05-07: Third Rock Ventures V, L.P., sold2026-05-11: Third Rock Ventures V, L.P., sold2026-05-26: Third Rock Ventures V, L.P., sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-30CHERYL GAULT, Chief Operating Officer$330,200
10,000 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-08-25KRISHNASWAMY YELESWARAM, Chief Development Officer$1,825,210
37,000 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-08-24KRISHNASWAMY YELESWARAM, Chief Development Officer$553,409
11,472 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-08-19KRISHNASWAMY YELESWARAM, Chief Development Officer$102,529
2,092 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-06-30CHERYL GAULT, Chief Operating Officer$403,900
10,000 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-06-29Abraham N. Ceesay, Chief Executive Officer$4,017,997
99,480 shplan 2026-03-27Form 4s on file end Jun 23144 ↗
2026-05-26Third Rock Ventures V, L.P., 10% Stockholder$742,880
18,572 sh10b5-1 plan144 ↗
Form 4, 2026-05-28: sold 18,572 at $40.05 Form 4 ↗
2026-05-11Third Rock Ventures V, L.P., 10% Stockholder$5,378,125
133,618 shplan 2025-11-21144 ↗
Form 4, 2026-05-13: sold 133,618 at $40.24 Form 4 ↗
2026-05-08Third Rock Ventures V, L.P., 10% Stockholder$202,255
5,018 shplan 2025-11-21Form 4s on file end Jun 23144 ↗
2026-05-07Third Rock Ventures V, L.P., 10% Stockholder$10.9M
271,495 shplan 2025-11-21144 ↗
Form 4, 2026-05-11: sold 276,513 at $40.12 Form 4 ↗
2026-04-17Third Rock Ventures V, L.P., 10% Stockholder$17.2M
426,005 shplan 2025-11-21144 ↗
Form 4, 2026-04-21: sold 426,005 at $40.32 Form 4 ↗
2026-04-17KRISHNASWAMY YELESWARAM, Chief Development Officer$799,697
20,225 shplan 2025-12-10144 ↗
Form 4, 2026-04-21: sold 20,225 at $39.99 Form 4 ↗
2026-04-13KRISHNASWAMY YELESWARAM, Chief Development Officer$661,702
19,365 shplan 2025-12-10Form 4s on file end Jun 23144 ↗
2026-04-10KRISHNASWAMY YELESWARAM, Chief Development Officer$17,110
500 shplan 2025-12-10144 ↗
Form 4, 2026-04-14: sold 19,865 at $35.03 Form 4 ↗
2026-04-08KRISHNASWAMY YELESWARAM, Chief Development Officer$12,056
360 shplan 2025-12-10144 ↗
Form 4, 2026-04-09: sold 360 at $34.90 Form 4 ↗
2026-03-30CHERYL GAULT, Chief Operating Officer$278,400
10,000 shplan 2025-12-10144 ↗
Form 4, 2026-03-31: sold 10,000 at $28.18 Form 4 ↗
2026-03-25KRISHNASWAMY YELESWARAM, Chief Development Officer$285,749
10,115 shplan 2025-12-10144 ↗
Form 4, 2026-03-26: sold 10,115 at $29.99 Form 4 ↗
2026-03-05Gault Cheryl, Chief Operating Officer$58,236
2,014 shplan 2025-12-10144 ↗
Form 4, 2026-03-09: sold 2,014 at $28.93 Form 4 ↗
2026-01-15DAVID BREDT, Chief Scientific Officer$466,140
17,000 shplan 2024-12-12144 ↗
Form 4, 2026-01-16: sold 8,500 at $26.84 Form 4 ↗
2026-01-02DAVID BREDT, Chief Scientific Officer$197,338
6,567 shno plan date144 ↗
Form 4, 2026-01-05: sold 6,567 at $30.05 Form 4 ↗
2026-01-02Krishnaswamy Yeleswaram, Chief Development Officer$85,343
2,840 shplan 2025-12-10144 ↗
Form 4, 2026-01-05: sold 2,840 at $30.05 Form 4 ↗
2025-12-17THE DOROTHY CEESAY IRREVOCABLE TRUST, Chief Executive Officer$469,059
15,249 shplan 2024-12-12144 ↗
Form 4, 2025-12-18: sold 10,916 at $29.64 Form 4 ↗
2025-12-17ABRAHAM CEESAY, Chief Executive Officer$538,269
17,499 shplan 2024-12-12no Form 4 on file144 ↗
2025-10-15DAVID BREDT, Chief Scientific Officer$634,440
25,500 shplan 2024-12-12144 ↗
Form 4, 2025-10-16: sold 8,500 at $25.78 Form 4 ↗